| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomea Fusion, Inc. (BMEA) has 7 insiders with recent SEC Form 4 filings, including 8 buys and 2 sells. BMEA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 723.0K | $1.11M | - | |
| Dir | 241.2K | $370.2K | - | |
| CEO | 115.0K | $176.5K | - | |
| ? | 92.0K | $141.2K | - | |
| Dir | 92.0K | $141.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 | Chen Bihua56 | - | Buy | 400,000 | $30.00 | $12,000,000.00 | +12.6% | -28.6% | -53.2% | |
| Nov 14, 2022 | Hitchcock Michael J.M.46 | Director | Buy | 5,000 | $7.93 | $39,650.00 | New | +31.7% | +11.5% | |
| Nov 11, 2022 | Valle Franco | Chief Financial Officer | Buy | 4,100 | $7.63 | $31,285.87 | +30.8% | +25.0% | +7.5% | |
| Aug 16, 2022 | A2a Pharmaceuticals, Inc.79 | 10% Owner | Buy | 30,684 | $13.87 | $425,648.45 | +0.7% | -41.4% | +24.3% | |
| Jul 21, 2022 | A2a Pharmaceuticals, Inc.79 | 10% Owner | Sell | 34,658 | $11.21 | $388,516.18 | -0.8% | -24.0% | +81.7% | |
| Jun 24, 2022 | A2a Pharmaceuticals, Inc.79 | 10% Owner | Sell | 34,658 | $11.76 | $407,578.08 | -0.8% | -7.9% | +156.7% | |
| Jan 14, 2022 | Valle Franco | Chief Financial Officer | Buy | 10,000 | $8.68 | $86,767.00 | New | -49.6% | -17.6% | |
| Sep 17, 2021 | A2a Pharmaceuticals, Inc.79 | 10% Owner | Buy | 34,658 | $10.96 | $379,851.68 | +0.8% | -30.4% | +5.9% | |
| Sep 17, 2021 | Stergiopoulos Sotirios | Director | Buy | 34,658 | $10.96 | $379,851.68 | +0.8% | -30.4% | +5.9% | |
| Aug 23, 2021 | Butler Thomas Andrew | CEO | Buy | 24,000 | $13.20 | $316,872.00 | +11.7% | -12.9% | -9.5% |